What is BCI?

How brain-computer interfaces redefine healthtech and neurotherapy

Brain-Computer Interfaces (BCIs) represent a frontier in neurotechnology and neurotherapy, offering a direct communication pathway between the human brain and external devices, like robotic arms or a computer. This revolutionary field aims to restore lost functions, enhance capabilities, and even treat complex neurological and mental health conditions.

From decoding thoughts into speech to controlling robotics, BCIs are a rapidly evolving medical device with the possibility of transforming the healthtech and neurotherapy market.

The primary focus of many BCI applications is on restoring function for individuals with neurological impairments. For instance, assistive communication medical devices allow patients who have lost the ability to speak or type to communicate through text or speech, or to directly operate a computer cursor or mouse. Pioneering efforts like the BrainGate clinical trial program exemplify this, showing impressive feats such as decoding imagined handwriting, which has set new records for BCI-based communication speed.

Beyond communication, BCIs are enabling precise control of robotic arms and cursors and even the restoration of movement in a user's own body through muscle stimulation. Therapeutic applications are also a powerful possibility, with BCI sensing and stimulation potentially enabling neurotherapy treatment for conditions like depression, epilepsy, Parkinson's disease, and chronic pain.

Intracortical BCIs are the cutting edge of neurotechnology

Diverse technologies underpin BCI development, each with unique advantages and trade-offs. One of the most promising BCI tools are intracortical BCIs, which involve the placement of microelectrodes 1 to 2 mm into the cortex, offering high temporal and spatial resolution measures of neural activity. 

Examples include microelectrode arrays like the Utah array, Neuropixels, and Paradromics Connexus® BCI, each penetrating brain tissue to record spikes from individual neurons. Paradromics and Neuralink are the top BCI makers developing high-data-rate implantable BCIs. Electrocorticography (ECoG), which records from the brain's surface, is another tool within the BCI technology space, although ECoG has some limitations since it is sensitive to the averaged activity of many neurons, missing out on the more detailed information available from spiking neurons. 

Non-invasive BCIs, such as Electroencephalography (EEG) and optical methods like functional Near-Infrared Spectroscopy (fNIRS), provide more compromised or indirect measures of brain activity. While EEG has been around for decades, its utility for complex real-time control can be limited due to comparatively poorer spatial and temporal resolution from the scalp. Optical techniques, like Kernel Flow's fNIRS, measure changes in blood oxygenation to infer neural activity, acting like a "pulse oximeter for your head."

Engineering breakthroughs power intracortical BCI technology

Significant technical and engineering advancements must be built for intracortical or implantable BCI devices, since the human body is a harsh, saline environment. This requires BCI technology that bridges the gap between cutting-edge semiconductor technology, often not designed for chronic biological use, and traditional medical device manufacturing. Miniaturization, power consumption, data rates, and the ability to operate near or within the brain without causing tissue damage are constant design considerations. At the same time, machine learning and AI are crucial for analyzing these vast datasets and identifying relevant brain states and biomarkers.

BCI Technology leads a new era of human-computer engagement

The advent of BCIs also introduces a complex ethical landscape. Questions of data privacy are paramount, as neural data contains intimate information, including potential biomarkers for mental states or even medication use. The immediacy of this data, revealing intent milliseconds before an action, raises concerns beyond those typically associated with other health data like genetic information. Identity, autonomy, and equitable access are also pressing issues. The line between restoring function and enhancing human capabilities, a topic that sparks both excitement and apprehension, is another important consideration for this revolutionary neurotechnology.

Overall, BCIs represent a huge potential for healthcare, mental health treatment, and society at large. Experts foresee a future where neurotechnologies are as commonplace and life-saving as cardiac pacemakers. To make it happen, expect to see collaborations across diverse disciplines like neuroscience, engineering, computer science, and even ethics, as these areas are all crucial in translating research into clinically viable medical devices. 

Companies and research institutions are increasingly focusing on patient-centric design, aiming for solutions that are not only technologically advanced but also intuitive, durable, and that genuinely improve people’s quality of life. As funding for neurotechnology expands and the neurotech market continues to grow, we anticipate a wave of innovations that will make currently unimaginable interventions a reality, fundamentally transforming the relationship between brains and machines.

If you have any questions, please reach out to media@paradromics.com.

References 
‍Canny, E., Vansteensel, M. J., van der Salm, S. M. A., Müller-Putz, G. R., & Berezutskaya, J. (2023). Boosting brain–computer interfaces with functional electrical stimulation: potential applications in people with locked-in syndrome. Journal of NeuroEngineering and Rehabilitation, 20, 157. https://doi.org/10.1186/s12984-023-01272-y

Parvizi, J., & Kastner, S. (2018). Promises and limitations of human intracranial electroencephalography. Nature Neuroscience, 21(4), 474–483. https://doi.org/10.1038/s41593-018-0108-2

Paulmurugan, K., Vijayaragavan, V., Ghosh, S., Padmanabhan, P., & Gulyás, B. (2021). Brain–Computer Interfacing Using Functional Near-Infrared Spectroscopy (fNIRS). Biosensors, 11(10), 389. https://doi.org/10.3390/bios11100389

Villa, J., Cury, J., Kessler, L., Tan, X., & Richter, C.-P. (2024). Enhancing biocompatibility of the brain-machine interface: A review. Bioactive Materials, 42, 531–549. https://doi.org/10.1016/j.bioactmat.2024.08.034

Willett, F. R., Avansino, D. T., Hochberg, L. R., Henderson, J. M., & Shenoy, K. V. (2021). High-performance brain-to-text communication via handwriting. Nature, 593(7858), 249–254. https://doi.org/10.1038/s41586-021-03506-2